A UK vaccine against coronavirus has shown “promising” results, findings of the first phases of the study suggest.
The early-stage trial showed the vaccine is “safe, causes few side effects, and induces strong immune responses,” results published in The Lancet said.
The vaccine, developed by the University of Oxford, is called ChAdOx1 nCoV-19.